Dr. Suresh Ramalingam, M.D.

Executive Director
Winship Cancer Institute
Emory University

Board certified in medical oncology, Suresh S. Ramalingam is nationally recognized as a researcher and  physician in the area of small cell and non-small cell lung cancer.

Ramalingam serves as executive director of Winship Cancer Institute of Emory University and associate vice president for cancer of Emory's Woodruff Health Sciences Center. He is past president of the Georgia Society of Oncology and a member of the board of Georgia CORE. He is also a fellow of the American Society of Clinical Oncology and a Georgia Cancer Coalition Distinguished Cancer Scholar.

Ramalingam holds professional memberships with the American Society of Clinical Oncology, American Association for Cancer Research and International Association of Lung Cancer Study. He plays an active role in the ECOG-ACRIN Cancer Research Group as the deputy chair of the Therapeutics Studies Program and as former chair of the Thoracic Malignancies Committee. He serves on several international, national and institutional committees and is a former member of the Medical Oncology Board Exam Committee for the American Board of Internal Medicine. He serves as a principal investigator for the Emory University lung cancer SPORE award from the National Cancer Institute.

Ramalingam is a graduate of Kilpauk Medical College at the University of Madras in Madras, India. He completed his residency in internal medicine at Wayne State University in Detroit, Michigan and his fellowship in hematology and medical oncology at the University of Pittsburgh Cancer Institute in Pittsburgh, Pennsylvania.

Ramalingam's research involves developing immune checkpoint inhibitors and improving outcomes for patients with EGFR mutations. He has conducted numerous phase 1, 2 and 3 clinical trials with molecularly targeted agents in the treatment of small cell and non-small cell lung cancer.